Radeya Global

Shenzhen Signal: Musk Pledges Tesla China Output Boost as SpaceX-Tesla Merger Talks Advance and Cybercab Orders Open

Elon Musk’s first public visit to Shenzhen during APEC week delivered a clear manufacturing commitment while broader corporate moves continued in parallel.

By Kokab Rahman, Founder & CEO, Radeya Global

On November 19, 2026, during meetings tied to the APEC Economic Leaders’ Week in Shenzhen, Musk told Ren Hongbin, chairman of the China Council for the Promotion of International Trade and chair of the APEC CEO Summit, that Tesla would continue increasing production in China. Chinese state-affiliated reporting (Yuyuan Tantian / CCTV) and Reuters carried the remarks. Tesla’s Shanghai factory delivered 810,889 Model 3 and Model Y vehicles in the first 10 months of 2026, up roughly 21.4 percent year-on-year. The plant, Tesla’s largest production base and main export hub, has annual capacity above 950,000 units and sources about 98 percent of parts locally while shipping to markets including Europe, South Korea, and Australia. Musk described himself as a “super fan” of China and called Shenzhen a leading advanced-technology center, while participating remotely in the New York Times DealBook Summit as a “digital me” because of the China trip.

The China comments arrive as Tesla opens limited personal Cybercab orders. On November 13, Tesla’s Robotaxi account invited select customers to order the two-seat, no-steering-wheel vehicle for personal use at an estimated $29,990 before taxes, plus a required Autonomy Subscription (initially listed at $299 per month after one included month) and a $1,000 non-refundable deposit. Estimated deliveries were listed for December 2026 in Austin; availability is invitation-only and tied to supported service areas. Musk later indicated the monthly fee should fall closer to roughly $115 to better match other Tesla software pricing. Texas registrations of Cybercabs have continued to climb alongside the company’s robotaxi operations. These steps mark a concrete shift from fleet-only testing toward customer ownership of the purpose-built autonomous vehicle, even as regulatory approvals and geographic limits remain in place.

At the same time, SpaceX and Tesla merger discussions have moved from high-level evaluation to more detailed talks on price and governance. Bloomberg reported on November 12 that the two companies’ special committees of independent directors and their advisers are negotiating terms, with an announcement possible as soon as December or potentially slipping into early 2027. SpaceX, which listed on Nasdaq in June 2026 after acquiring the former xAI business earlier in the year, and Tesla each formed the committees in October. Musk has described a combination as having “a lot of merit” given overlaps in AI software, chip design, robotics, connectivity, and the joint Terafab semiconductor project in Texas. He has recused himself as a conflicted party; any deal would still need committee and board approvals plus a high Tesla shareholder threshold (a majority of all outstanding shares). Market values cited in coverage place SpaceX near $1.9–2 trillion and Tesla in the $1.5 trillion range, which would make any completed transaction the largest in corporate history. Terafab remains a key shared initiative targeting test chips in 2027 and volume production around the third quarter of 2028, aimed at supplying custom silicon for vehicles, robots, and compute needs.

Neuralink continues parallel technical work. In late October, Musk stated that Blindsight—the company’s second product, intended to restore vision for people who are completely blind or have never seen—is ready from an engineering standpoint and awaits regulatory approval. It holds FDA Breakthrough Device Designation (announced in 2024), which prioritizes development and review but does not constitute marketing authorization. Telepathy, the first product focused on high-bandwidth thought-to-computer or thought-to-speech interfaces, remains in clinical trials. No public human Blindsight implant results have been reported as of mid-November.

For executives and businesses, these developments underscore continued dual-track investment in China manufacturing capacity alongside vertical integration efforts in chips, autonomy, and AI infrastructure. Supply-chain managers tracking Gigafactory Shanghai exports and local content rates will note the explicit production-growth signal, while M&A and strategy teams should monitor the SpaceX-Tesla committees for any formal proposal ahead of Tesla’s December 3 annual meeting. Autonomy and robotics suppliers face a clearer path as Cybercab moves toward limited customer deliveries.

Job seekers in manufacturing operations, battery and vehicle production, semiconductor process engineering, AI training infrastructure, and autonomous-systems software will see expanding demand signals across Tesla’s China operations, the Texas Terafab effort, SpaceX’s compute build-out, and robotaxi scaling. Roles that combine hardware manufacturing with software or systems integration remain especially relevant as the companies pursue closer coordination.

The next several weeks will clarify whether merger discussions produce a concrete proposal and how quickly Cybercab customer vehicles enter service areas. Both developments sit alongside ongoing Starship reusability work and AI capacity expansion already covered elsewhere on this blog.

About Radeya Global

At Radeya Global we help professionals and businesses turn these market signals into practical advantages — through targeted career strategy, resume and profile optimization, interview preparation, and custom business advisory support. Ready to take action? Explore our career optimization and job search services, or reach out for business consulting support. You can also email us or visit www.radeya.biz.

Radeya Global – Premium Business & Career Solutions.